Table 1.
Centers for Disease Control and Prevention criteria for multisystem inflammatory syndrome in children
| CDC Criteria for MIS-C |
| Age <21 yr |
| Clinical presentation consistent with MIS-C, including all of the following |
| Fever |
| Documented fever >38.0°C (100.4°F) for ≥24 h or report of subjective fever lasting ≥24 h |
| Laboratory evidence of inflammation including, but not limited to, any of the following |
| Elevated CRP |
| Elevated ESR |
| Elevated fibrinogen |
| Elevated procalcitonin |
| Elevated d-dimer |
| Elevated ferritin |
| Elevated LDH |
| Elevated IL-6 level |
| Neutrophilia |
| Lymphocytopenia |
| Hypoalbuminemia |
| Severe illness requiring hospitalization |
| Multisystem involvement—two or more organ systems involved |
| Cardiovascular (e.g., shock, elevated troponin, elevated BNP, abnormal echocardiogram, arrhythmia) |
| Respiratory (e.g., pneumonia, ARDS, pulmonary embolism) |
| Renal (e.g., AKI, renal failure) |
| Neurologic (e.g., seizure, stroke, aseptic meningitis) |
| Hematologic (e.g., coagulopathy) |
| Gastrointestinal (e.g., elevated liver enzymes, diarrhea, ileus, gastrointestinal bleeding) |
| Dermatologic (e.g., erythroderma, mucositis, other rash) |
| No alternative plausible diagnoses |
| Recent or current SARS-CoV-2 infection or exposure |
MIS-C, multisystem inflammatory syndrome in children; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase; BNP, B-type natriuretic peptide; ARDS, acute respiratory distress syndrome; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.